E-Selectin, antagonists & inhibitors
- Name
- E-Selectin, antagonists & inhibitors
- Accession Number
- DBCAT005551
- Description
Not Available
- Drugs
Drug Drug Description Uproleselan Uproleselan is a novel, specific E-Selectin antagonist under investigation in clinical trial NCT02306291 (Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML). - Drugs & Drug Targets
Drug Target Type